Sub-endometrial injection of vasopressin for invasive placenta

Phase 3

• Conditions: O00.0; pregnancy with placenta accreta.; Abdominal pregnancy

• Registration Number: IRCT20191102045310N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

All pregnant women with placenta accreta diagnosed by ultrasound

Exclusion Criteria

History of cardiac diseases
History of uncontrolled hypertension
History of pelvic pregnancies
History of chronic obstructive pulmonary disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin level decrement. Timepoint: Before and after cesarean section. Method of measurement: Cell Blood Count test done by the hospital laboratory.